Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes — Variants & evidence · CancerIndex

Variants & evidence

Curated clinical evidence by variant and therapy

2 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.

civicCuratedShowing 1–2 of 2 evidence items (2 on this page mapped to a descendant entity) · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Cancer	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
CD79B MUTATION1
(diagnostic)	MCD Diffuse Large B-Cell Lymphoma	Diagnostic	E	Supports Positive	3	submitted	EID11822 This is one of the genetic features of this subgroup PMID 32289277 · Wright et al., 2020 · Open in CIViC	civic
GNAI2 mutation1
(oncogenic)	EZB Diffuse Large B-Cell Lymphoma	Oncogenic	E	Supports Oncogenicity	4	submitted	EID11943 The study identified recurrently mutated genes in DLBCL using whole genome sequencing. PMID 23699601 · Morin et al., 2013 · Open in CIViC	civic

Data updated 5 hours agoSource updated unknownsource: civic (CC0)

Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.